
Madrigal Pharmaceuticals Receives Positive CHMP Opinion for Resmetirom in Treating MASH
CONSHOHOCKEN, PA — The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Madrigal Pharmaceuticals’ (NASDAQ: …
Madrigal Pharmaceuticals Receives Positive CHMP Opinion for Resmetirom in Treating MASH Read More